000 | 01912 a2200565 4500 | ||
---|---|---|---|
005 | 20250516085622.0 | ||
264 | 0 | _c20130408 | |
008 | 201304s 0 0 eng d | ||
022 | _a1349-7006 | ||
024 | 7 |
_a10.1111/j.1349-7006.2012.02306.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPils, Dietmar | |
245 | 0 | 0 |
_aValidating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium. _h[electronic resource] |
260 |
_bCancer science _cJul 2012 |
||
300 |
_a1334-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aEuropean Union |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xclassification |
650 | 0 | 4 |
_aOligonucleotide Array Sequence Analysis _xstatistics & numerical data |
650 | 0 | 4 |
_aOvarian Neoplasms _xclassification |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProportional Hazards Models |
700 | 1 | _aHager, Gudrun | |
700 | 1 | _aTong, Dan | |
700 | 1 | _aAust, Stefanie | |
700 | 1 | _aHeinze, Georg | |
700 | 1 | _aKohl, Maria | |
700 | 1 | _aSchuster, Eva | |
700 | 1 | _aWolf, Andrea | |
700 | 1 | _aSehouli, Jalid | |
700 | 1 | _aBraicu, Ioana | |
700 | 1 | _aVergote, Ignace | |
700 | 1 | _aCadron, Isabelle | |
700 | 1 | _aMahner, Sven | |
700 | 1 | _aHofstetter, Gerda | |
700 | 1 | _aSpeiser, Paul | |
700 | 1 | _aZeillinger, Robert | |
773 | 0 |
_tCancer science _gvol. 103 _gno. 7 _gp. 1334-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1349-7006.2012.02306.x _zAvailable from publisher's website |
999 |
_c21699240 _d21699240 |